Appearance is everything, at least that’s how the saying goes, and for pharma...
Public image limited: the role of PR in pharma
Appearance is everything, at least that’s how the saying goes, and for pharma companies maintaining a positive and trustworthy reputation isn’t always easy. So how does Big Pharma establish and keep its public image in check, and how do companies recover when things go very wrong?
Goldfinch acquires global rights to Takeda’s monoclonal antibody
US-based clinical-stage biotechnology company Goldfinch Bio has entered an agreement with Japanese firm Takeda Pharmaceutical for global rights to a preclinical, peripherally restricted cannabinoid receptor 1 (CB1) monoclonal antibody.
GSK to raise $1.26bn by selling consumer health brands
GlaxoSmithKline (GSK) has reportedly started selling some of its consumer health brands to raise around £1bn ($1.26bn) in preparation for its spinoff plans.
ProAmpac updates child-resistant pouch product line
Flexible packaging manufacturer ProAmpac has unveiled an updated range of child-resistant, reclosable, easy-open (CRREO) pouches in an expanded range of sizes.
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.